KLEIN JOSEPH III 4
4 · IONIS PHARMACEUTICALS INC · Filed Sep 4, 2025
Insider Transaction Report
Form 4
KLEIN JOSEPH III
Director
Transactions
- Exercise/Conversion
Common Stock
2025-09-03+16,000→ 16,000 total(indirect: By Trust) - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-09-03−12,000→ 0 total(indirect: By Trust)Exercise: $42.88From: 2019-07-02Exp: 2028-07-01→ Common Stock (12,000 underlying) - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-09-03−16,000→ 0 total(indirect: By Trust)Exercise: $52.22From: 2018-07-03Exp: 2027-07-02→ Common Stock (16,000 underlying) - Sale
Common Stock
2025-09-03$60.00/sh−28,000$1,680,000→ 0 total(indirect: By Trust) - Exercise/Conversion
Common Stock
2025-09-03+12,000→ 28,000 total(indirect: By Trust)
Holdings
- 16,346
Common Stock
- 100(indirect: by Son)
Common Stock
Footnotes (2)
- [F1]Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on January 3, 2024
- [F2]The reporting person disclaims beneficial ownership of all securities held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.